← All trials
NCT06051721
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 6, 2024
- Primary completion
- Sep 20, 2024
- Completion date
- Dec 14, 2024
- First posted
- Sep 25, 2023
- Last posted
- Sep 25, 2023
- Enrollment
- 36
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Cybin Therapeutics Inc.Lead sponsor
- Worldwide Clinical TrialsCollaborator
- Cybin Therapeutics Inc.Study director
- Cybin Therapeutics Inc.Official
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.